Channel Therapeutics Corporation

CHRO XASE • BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

7.8M

Short interest (May 30)

1.9%

Net Short (Jul 01 ): -0.4%

Borrow Fee

141.12%

↓ 18.8%

Available Shares

20K

↓ 63.5%

Price Chart

Company Overview

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Company Info

Exchange: XASE

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

CIK: 0001919246

Asset Type: CS

Market Data

Market Cap: $7,783,103

Employees: 11

Status: Active

Short Interest

Current Borrow Fee 141.12%

Range: 135.97% - 141.12%

Available Shares 20K

Range: 10K - 20K

Recent Changes

Fee Change: ↑ 10.4%

Available Change: ↓ 25.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime